Skip to main content

Metadate CD

(methylphenidate CD)

Full Prescribing Information DailyMed Drug Information

Forms/Strengths

  • Capsules: 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg

Dosing

  • Age: ≥ 6 y/o
  • Onset: ~ 30-60 min
  • Duration: 8-12 hours
  • Release Profile: 30% IR, 70% ER
  • Considerations: The capsule can be opened, and beads can be swallowed with applesauce. Take orally once daily in the morning, preferably before breakfast.
  • Initial Dose: 20 mg
  • Titration: 10-20 mg weekly
  • Max Dose: 60 mg/day 

Quick Facts

  • Blocks dopamine/norepinephrine reuptake; enhances focus, attention, impulse control
  • Extended-release methylphenidate capsule with biphasic release: immediate and delayed
  • Immediate portion for rapid onset; delayed portion for sustained effect and optimized plasma levels
  • Common side effects: decreased appetite, insomnia, headache, stomach upset

Indications

  •  ADHD (ICD-10: F90.0)

Off-Label Uses

  • N/A 

How to Take

  • Take once daily in the morning to minimize the risk of insomnia.
  • Can be taken with or without food; high-fat meals may delay absorption.
  • Swallow the capsule whole; do not crush or chew.
  • If needed, the capsule may be opened and sprinkled on applesauce—consume immediately without chewing.

Side Effects

  • Common: Anorexia, insomnia, headache, abdominal pain.
  • Serious: Cardiovascular events, psychiatric adverse reactions, growth suppression, priapism, peripheral vasculopathy

Monitoring / Labs

  • Cardiovascular: Baseline and routine monitoring of heart rate and blood pressure.
  • Growth in Pediatrics: Regular monitoring of height and weight to detect growth suppression.
  • Psychiatric Symptoms: Observe for mood changes, anxiety, or psychosis.
  • Abuse Potential: Monitor for misuse or diversion.

Education

  • When to Call the Doctor:

    • Severe mood changes, aggression, or suicidal thoughts.
    • Chest pain, rapid heartbeat, shortness of breath (cardiovascular concerns).
    • Uncontrolled movements, tics, or worsening anxiety.
    • Numbness, coldness, or color changes in fingers or toes (circulatory issues).
    • Unexplained weight loss or delayed growth in pediatric patients.
  • Safety Tips:

    • Monitor blood pressure and heart rate, especially in patients with cardiovascular risk.
    • Use caution in patients with anxiety, bipolar disorder, or psychosis, as symptoms may worsen.
    • Avoid caffeine and other stimulants, which may amplify side effects.
    • Ensure adequate hydration and nutrition, as appetite suppression is common.
    • Tapering may be required if discontinuing after long-term use.
  • Parent Tips for Pediatric Patients:

    • Encourage a nutrient-dense diet to counteract appetite suppression.
    • Administer in the morning before school for optimal effect.
    • Monitor school performance and behavioral changes.
    • Observe for sleep disturbances; adjust timing if necessary.
    • Communicate regularly with teachers and caregivers about medication effects.

Additional Information

  • Contraindications:

    • Hypersensitivity to methylphenidate or formulation components.
    • Use within 14 days of MAOI therapy (risk of hypertensive crisis).
    • Symptomatic cardiovascular disease, moderate-to-severe hypertension, hyperthyroidism, glaucoma.
    • History of substance use disorder, unless benefits outweigh risks.
  • Pregnancy:

    • Category C; use only if benefits outweigh risks.
    • May cause neonatal withdrawal symptoms or low birth weight.
  • Lactation:

    • Excreted in breast milk; not recommended due to potential infant exposure.
  • Drug Interactions:

    • Serotonergic drugs (e.g., SSRIs, SNRIs, MAOIs) increase serotonin syndrome risk.
    • Acidifying agents (e.g., ascorbic acid) may reduce drug absorption.
    • Alkalinizing agents (e.g., sodium bicarbonate) may increase methylphenidate levels.
    • May potentiate hypertensive effects of certain medications (e.g., decongestants, beta-agonists).